2012•Zhongguo manxingbing yufang yu kongzhiRequires access

The Efficacy of Insulin Glargine Combined with Acarbose in Patients with Fluctuating High Blood Glucose

Yang Rongli

Open publisher page 0 citations

Abstract

Objective To study on the efficacy and safety of insulin glargine combined with acarbose in elderly patients newly diagnosed type 2 diabetic mellitus with fluctuating high blood glucose. Methods 30 of patients with fluctuating high blood glucose were selected and given insulin glargine combined with acarbose besides diet control for three months, and their fluctuation of blood glucose was observed at the beginning and the end of the study. Results HbA1C, MBG, SDBG, MAGE and MODD were significantly lower at the beginning than at the end[7.37%±0.47% vs 8.29%±0.73%, (8.04±2.25) vs (10.06±2.48) mmol/L, (1.52±0.35) vs ( 2.36±0.53) mmol/L, (4.40±1.02) vs (5.64±1.22) mmol/L, (1.26±0.49) vs (1.72±0.60) mmol/L, respectively; P0.05 or P0.01]. Conclusion It might be more effective and safer for elderly patients with type 2 diabetic mellitus to use insulin glargine combined with acarbose in controlling level and fluctuation of blood sugar.

About this research paper

What this paper is about

Objective To study on the efficacy and safety of insulin glargine combined with acarbose in elderly patients newly diagnosed type 2 diabetic mellitus with fluctuating high blood glucose. Methods 30 of patients with fluctuating high blood glucose were selected and given insulin glargine combined with acarbose besides diet control for three months, and their fluctuation of blood glucose was observed at the beginning and the end of the study. Results HbA1C, MBG, SDBG, MAGE and MODD were significantly lower at the beginning than at the end[7.37%±0.47% vs 8.29%±0.73%, (8.04±2.25) vs (10.06±2.48) mmol/L, (1.52±0.35) vs ( 2.36±0.53) mmol/L, (4.40±1.02) vs (5.64±1.22) mmol/L, (1.26±0.49) vs (1.72±0.60) mmol/L, respectively; P0.05 or P0.01]. Conclusion It might be more effective and safer for elderly patients with type 2 diabetic mellitus to use insulin glargine combined with acarbose in controlling level and fluctuation of blood sugar.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study on the efficacy and safety of insulin glargine combined with acarbose in elderly patients newly diagnosed type 2 diabetic mellitus with fluctuating high blood glucose. Methods 30 of patients with fluctuating high blood glucose were selected and given insulin glargine combined with acarbose besides diet control for three months, and their fluctuation of blood glucose was observed at the beginning and the end of the study. Results HbA1C, MBG, SDBG, MAGE and MODD were significantly lower at the beginning than at the end[7.37%±0.47% vs 8.29%±0.73%, (8.04±2.25) vs (10.06±2.48) mmol/L, (1.52±0.35) vs ( 2.36±0.53) mmol/L, (4.40±1.02) vs (5.64±1.22) mmol/L, (1.26±0.49) vs (1.72±0.60) mmol/L, respectively; P0.05 or P0.01]. Conclusion It might be more effective and safer for elderly patients with type 2 diabetic mellitus to use insulin glargine combined with acarbose in controlling level and fluctuation of blood sugar.

Key concepts: Acarbose, Medicine, Insulin glargine, Internal medicine, Blood sugar, Type 2 Diabetes Mellitus, Endocrinology, Insulin

Related papers

Back to paper searchBrowse research topicsOriginal source
The Efficacy of Insulin Glargine Combined with Acarbose in Patients with Fluctuating High Blood Glucose — Research Paper | ScholarLens